A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 459
Last updated 2016-03-15
Summary
This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.
Conditions
- Migraine Disorders
- Headache
Interventions
- OTHER
-
No Intervention
There is no intervention in this study.
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Director · Allergan
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
NCT01749423 ·Status: WITHDRAWN
-
The Effect of Sumatriptan and Placebo on CGRP Induced Headache
NCT03542357 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Study of MAP0004 in Adult Migraineurs
NCT00623636 ·Status: COMPLETED ·Phase: PHASE3
-
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
NCT04592952 ·Status: UNKNOWN ·Phase: PHASE4
-
Cluster Headache Treatment With Rimegepant
NCT05264714 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
NCT01516892 ·Status: COMPLETED ·Phase: PHASE4
-
Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption
NCT05232942 ·Status: RECRUITING
-
A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches
NCT00168428 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study Of Migraine Evolution
NCT00460005 ·Status: COMPLETED
-
Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®
NCT02502123 ·Status: COMPLETED
-
A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
NCT01749410 ·Status: COMPLETED
-
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496 ·Status: COMPLETED
-
Diet and Migraine Study
NCT01859052 ·Status: TERMINATED ·Phase: NA
-
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
NCT06485336 ·Status: RECRUITING ·Phase: PHASE2
-
Transcriptomic and Biochemical Changes During a Migraine Attack
NCT02468622 ·Status: COMPLETED
-
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
NCT01435941 ·Status: COMPLETED
-
Effect of Acetyl-L-carnitine in Migraine
NCT01695317 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
NCT05518123 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
NCT04299958 ·Status: COMPLETED
-
Prophylactic Effect of Memantine in Chronic Tension-Type Headache
NCT00315666 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
NCT04084314 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
NCT00660192 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study
NCT02895256 ·Status: UNKNOWN
-
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839 ·Status: COMPLETED ·Phase: NA
-
Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine
NCT04361721 ·Status: UNKNOWN